Annual report pursuant to Section 13 and 15(d)

Schedule of Stock-Based Compensation Expense (Details)

v3.22.4
Schedule of Stock-Based Compensation Expense (Details) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
Total stock-based compensation expense $ 14,991 $ 9,599
2018 Equity Plan [Member] | Cost Of Revenue [Member]    
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
Total stock-based compensation expense 13
2018 Equity Plan [Member] | Selling and Marketing Expense [Member]    
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
Total stock-based compensation expense 968 8
2018 Equity Plan [Member] | General and Administrative Expense [Member]    
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
Total stock-based compensation expense 12,691 9,073
2018 Equity Plan [Member] | Research and Development Expense [Member]    
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
Total stock-based compensation expense 187 66
PAVmed Inc 2014 Equity Plan [Member] | Selling and Marketing Expense [Member]    
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
Total stock-based compensation expense 654 202
PAVmed Inc 2014 Equity Plan [Member] | General and Administrative Expense [Member]    
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
Total stock-based compensation expense 262 38
PAVmed Inc 2014 Equity Plan [Member] | Research and Development Expense [Member]    
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
Total stock-based compensation expense 213 212
PAVmed Inc 2014 Equity Plan [Member] | Cost Of Revenue Expense [Member]    
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
Total stock-based compensation expense $ 3